eMedicine Specialties > Orthopedic Surgery > Neoplasms

Hemangioma: Workup

Author: Danielle A Katz, MD, Assistant Professor, Department of Orthopedic Surgery, State University of New York Upstate Medical University
Coauthor(s): Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Contributor Information and Disclosures

Updated: Nov 17, 2008

Workup

Laboratory Studies

  • If a patient presents with history, physical examination findings, and imaging study findings consistent with hemangioma, no laboratory studies are necessary.
  • For patients with intramuscular hemangiomas who manifest petechiae, easy bruising, or ecchymoses, consider the diagnosis of Kasabach-Merritt syndrome.
    • In Kasabach-Merritt syndrome, a CBC (for hemoglobin, hematocrit, and platelets) and coagulation studies (eg, prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, fibrinogen degradation products) are recommended for evaluation.
    • Hemoglobin and hematocrit can be decreased if hemorrhage is significant. Platelet counts can fall to 20,000 or less. Coagulation studies reveal that prothrombin time may be mildly elevated. Serum fibrinogen may be decreased, while fibrin degradation products may be elevated.
  • If tumor-induced osteomalacia is suspected based on radiographic findings, check serum calcium, phosphorus, parathyroid hormone, and alkaline phosphatase. Serum calcium will be in the low-to-normal range, marked hypophosphatemia will be present, parathyroid hormone will be within the reference range, and alkaline phosphatase will be elevated.

Imaging Studies



Cortical thickening of the tibia adjacent to an i...

Cortical thickening of the tibia adjacent to an intramuscular hemangioma of the leg.

Cortical thickening of the tibia adjacent to an i...

Cortical thickening of the tibia adjacent to an intramuscular hemangioma of the leg.


Radiograph showing phleboliths in an intramuscula...

Radiograph showing phleboliths in an intramuscular hemangioma of the thigh.

Radiograph showing phleboliths in an intramuscula...

Radiograph showing phleboliths in an intramuscular hemangioma of the thigh.


T1 and T2 MRI images of intramuscular hemangioma ...

T1 and T2 MRI images of intramuscular hemangioma of the leg. Note the serpentine quality of the vessels and that the hemangioma is high signal on both T1 and T2. This indicates that the hemangioma is predominantly of water density.

T1 and T2 MRI images of intramuscular hemangioma ...

T1 and T2 MRI images of intramuscular hemangioma of the leg. Note the serpentine quality of the vessels and that the hemangioma is high signal on both T1 and T2. This indicates that the hemangioma is predominantly of water density.


MRI (sagittal cut) illustrating the jailhouse app...

MRI (sagittal cut) illustrating the jailhouse appearance of a vertebral hemangioma.

MRI (sagittal cut) illustrating the jailhouse app...

MRI (sagittal cut) illustrating the jailhouse appearance of a vertebral hemangioma.


Axial cut on CT scan illustrating the polka dot a...

Axial cut on CT scan illustrating the polka dot appearance of an intraosseous vertebral hemangioma.

Axial cut on CT scan illustrating the polka dot a...

Axial cut on CT scan illustrating the polka dot appearance of an intraosseous vertebral hemangioma.


MRI of a pedunculated synovial hemangioma of the ...

MRI of a pedunculated synovial hemangioma of the knee. (T2 image with time to repetition [TR]=25.4, time to echo [TE]=9.0/1.)

MRI of a pedunculated synovial hemangioma of the ...

MRI of a pedunculated synovial hemangioma of the knee. (T2 image with time to repetition [TR]=25.4, time to echo [TE]=9.0/1.)


Radiograph of a patient with Gorham disease showi...

Radiograph of a patient with Gorham disease showing dissolution of bone.

Radiograph of a patient with Gorham disease showi...

Radiograph of a patient with Gorham disease showing dissolution of bone.


Low-power view of the histology of an intramuscul...

Low-power view of the histology of an intramuscular hemangioma. Note the vascular channels.

Low-power view of the histology of an intramuscul...

Low-power view of the histology of an intramuscular hemangioma. Note the vascular channels.


  • Intramuscular hemangiomas
    • Radiography16,17
      • Soft-tissue hemangiomas may be seen on radiographs as soft-tissue shadows, although typically they are isodense with muscle.
      • Soft-tissue hemangiomas may cause benign-appearing periosteal reaction, or chronic cortical thickening and remodeling in adjacent bone (see Image 1).
      • Phleboliths within the soft-tissue mass are diagnostic but are not common. These small, round, calcified densities occur within organizing thrombi within the vascular structures of hemangiomas (see Image 2).
    • MRI16,17
      • After plain radiography, an MRI is the imaging modality of choice for soft-tissue hemangiomas, including those of muscle and synovium (see Image 3).
      • Hemangiomas show increased signal on both T1- and T2-weighted images, frequently with areas of signal void. These void areas may be indicative of dense fibrous tissue, thrombi, phleboliths, or regions of high flow.
      • The diagnosis of hemangioma may be made with MRI when these signal characteristics are present and when the serpentine pattern of the vascular structures is depicted, usually with interposed fat as well. The margins of hemangiomas range from very infiltrative and irregular to well marginated.
      • Increased signal with gadolinium enhancement also may be helpful in distinguishing hemangiomas from other soft-tissue masses.
    • Angiography16,17
      • Angiography reveals a highly vascular lesion with vessels oriented parallel to one another.
      • The lesions may be high flow or low flow. This distinction between high flow and low flow can be important in treatment decisions, as high-flow lesions are more likely to benefit from embolization than are low-flow lesions.
  • Synovial hemangiomas18
    • Radiography
      • Synovial hemangiomas result in nonspecific changes on plain radiographs, occasionally including a vague soft-tissue density.
      • Erosion of bone is rarely present.
    • MRI
      • MRI is useful in the diagnosis of synovial hemangiomas.
      • The signal characteristics are similar to those of intramuscular hemangiomas (increased signal on T1 and T2, and depiction of vascular structures).
      • In addition, MRI can provide information as to whether a synovial hemangioma is localized and pedunculated or diffuse (see Image 7). This information helps in planning treatment.
      • Finally, MRI can be used to diagnose other pathologic processes in the differential diagnosis of a synovial hemangioma (eg, meniscal tear).
    • Angiography: This study reveals pooling over the mass, consistent with a vascular process.
  • Osseous hemangiomas
    • Radiography: Hemangiomas of bone have different radiographic characteristics in different anatomic locations.
      • In the skull, they produce lytic lesions that are well circumscribed and may have a honeycomb appearance. Frequently, fine, radiating striations are present, creating a sunburst or sunray appearance. The cortex often is expanded in the skull.
      • In the vertebral bodies, the parallel vertical trabeculae have a pathognomonic appearance, often referred to as "corduroy cloth" or "jailhouse" appearance (see Image 8). The cortex is not expanded in the vertebrae.
      • In the long bones, radiographic findings typically are less specific, with a coarse or bubbly appearance. Occasionally, the appearance may be primarily or completely lytic with a sclerotic rim.
    • Computed tomography
      • CT scan occasionally is used in identification of osseous hemangiomas but generally is not used to evaluate soft-tissue hemangiomas.
      • Vertebral body hemangiomas have a distinctive polka-dot appearance on axial CT scan (see Image 5).
    • MRI
      • In MRI of osseous hemangiomas, signal is increased on T1 and T2 and in the presence of vascular structures.
      • Vertebral hemangiomas can be identified by the jailhouse appearance on sagittal sections (see Image 4, similar to that seen on radiographs) and by the polka-dot appearance seen on axial sections (as on CT scan, see Image 5).
  • Gorham disease – Radiography: Massive osteolysis is evidenced by what appears to be dissolution of a bone or of adjacent bones in which the ends become tapered (see Image 9).

Diagnostic Procedures

  • Intramuscular hemangiomas
    • The differential diagnosis for the clinical and radiographic findings associated with intramuscular hemangiomas includes soft-tissue sarcoma. Therefore, when the clinical and radiographic findings are equivocal, biopsy is indicated (see Images 10-11).
    • Biopsy can be performed by needle or open techniques. Excessive bleeding should be anticipated in most cases.
  • Osseous hemangiomas
    • The most significant entities in the differential diagnosis of hemangioma of bone are osseous angiosarcoma and metastatic disease.19
    • As with soft-tissue hemangiomas, when the clinical and radiographic findings are equivocal, biopsy is indicated.
    • Biopsy can be performed by needle or open techniques.

Histologic Findings

Hemangiomas may have a spectrum of histologic findings. In a simplistic classification schema, hemangiomas can be divided into capillary (small vessel), cavernous (large vessel), and mixed types. Capillary hemangiomas have abundant vessels approximately 10-100 microns in diameter with walls 1-3 cells thick. The vessels tend to run in parallel. There is a single layer of endothelial cells with no shedding and no anaplasia. Cavernous hemangiomas have a similar appearance, but the lumina are bigger. A cellular type also has been described in which a much higher number of cells are present, distinct lumina are still identifiable, and no shedding or anaplasia is seen. There may be smaller areas within a cellular type that resemble capillary hemangiomas.

Using a more refined classification schema, Enzinger and Weiss divide localized hemangiomas into 7 categories, as follows20 :

  • Capillary hemangioma, including juvenile
  • Cavernous hemangioma
  • Venous hemangioma
  • Arteriovenous hemangioma (racemose hemangioma)
  • Epithelioid hemangioma
  • Hemangioma of granulation tissue
  • Miscellaneous hemangiomas of deep soft tissue (including many of the hemangiomas important to orthopedists, specifically synovial and intramuscular hemangiomas)

Cells within a hemangioma can be stained for factor VIII; positivity indicates that the cells are endothelial. Recently, each of 3 suggested phases of hemangioma development (proliferative, involuting, and involuted) has been defined histochemically and immunohistochemically by a group in New Zealand. Both CD31 and von Willebrand factor stain vascular endothelial cells in tumors of each phase. Proliferating cell nuclear antigen was predominant in the proliferative and involuting hemangiomas, but negligible in the involuting phase. Mast cells were identified predominately in the involuting phase hemangiomas. Vascular endothelial growth factor was identified primarily during the proliferative phase. Basic fibroblast growth factor was identified during the proliferative and early involuting phases. While these studies generally are not necessary for diagnosis, they provide insight into the biology and development of hemangioma.

Electron microscopy can be used to identify Weibel-Palade bodies. Weibel-Palade bodies are rod-shaped, 0.1-0.3 microns in length, and contain parallel tubules that localize factor VIII-associated antigen. They are relatively specific to endothelial cells.

Intramuscular hemangiomas

Intramuscular hemangiomas may be capillary, cavernous, or mixed in type. Intramuscular hemangiomas can be distinguished from skeletal-muscle angiosarcomas because they do not develop the freely anastomosing sinusoidal pattern seen in certain angiosarcomas. In addition, hemangiomas do not have the nuclear pleomorphism and hyperchromatism seen in angiosarcomas. It may be more difficult to distinguish hemangiomas from hemangioendotheliomas, but hemangioendotheliomas may have shedding and cellular atypia. Hemangiomas can be differentiated from angiolipomas by the absence of lipoblasts in hemangiomas.

Synovial hemangiomas

Synovial hemangiomas are of the cavernous type. The matrix between the vessels may be edematous, myxoid, or focally hyalinized. The cells may contain significant amounts of hemosiderin.

Osseous hemangiomas

Most hemangiomas of bone are cavernous, although they may be mixed capillary and cavernous. There may be reactive new-bone formation, which can appear similar to an osteoblastoma. Hemangioendothelioma of bone may be distinguished by a plumper endothelial lining and varying degrees of cellular atypia.

Gorham disease

Histologic evaluation of Gorham disease typically reveals hypervascular bone. The vascular proliferation often fills the medullary canal.

More on Hemangioma

Overview: Hemangioma
Workup: Hemangioma
Treatment: Hemangioma
Follow-up: Hemangioma
Multimedia: Hemangioma
References

References

  1. Mulliken JB. Cutaneous vascular anomalies. In: McCarthy JG, May JW Jr, Littler JW, eds. Plastic Surgery: Tumors of the Head & Neck and Skin. Philadelphia:. WB Saunders Co;1990:3191-3223.

  2. Godanich IF, Campanacci M. Vascular hamartomata and infantile angioectatic osteohyperplasia of the extremities. J Bone Joint Surg. 1962;44A:815.

  3. Metry D. Update on hemangiomas of infancy. Curr Opin Pediatr. 2004;16:373-377.

  4. Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila). Nov-Dec 2005;44(9):747-66. [Medline].

  5. Canavese F, Soo BC, Chia SK, Krajbich JI. Surgical outcome in patients treated for hemangioma during infancy, childhood, and adolescence: a retrospective review of 44 consecutive patients. J Pediatr Orthop. Apr-May 2008;28(3):381-6. [Medline].

  6. Holzapfel BM, Geitner U, Diebold J, Glaser C, Jansson V, Dürr HR. Synovial hemangioma of the knee joint with cystic invasion of the femur: a case report and review of the literature. Arch Orthop Trauma Surg. Aug 30 2008;[Medline].

  7. Melman L, Johnson FE. Intramuscular cavernous hemangioma. Am J Surg. Jun 2008;195(6):816-7. [Medline].

  8. Muramatsu K, Ihara K, Tani Y, Chagawa K, Taguchi T. Intramuscular hemangioma of the upper extremity in infants and children. J Pediatr Orthop. Apr-May 2008;28(3):387-90. [Medline].

  9. Devaney K, Vinh TN, Sweet DE. Skeletal-extraskeletal angiomatosis. A clinicopathological study of fourteen patients and nosologic considerations. J Bone Joint Surg Am. Jun 1994;76(6):878-91. [Medline].

  10. Geschickter CF, Keasbey LE. Tumors of blood vessels. Am J Cancer. 1935;23:568, 591.

  11. Watson WL, McCarthy WD. Blood and lymph vessel tumors. A report of 1056 cases. Surg Gynecol Obstet. 1940;71:569-88.

  12. Mirra JM. Vascular tumors. In: Mirra JM, ed. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Vol 2. Philadelphia:. Lea & Febiger;1989:1336-1377.

  13. Chang J, Most D, Bresnick S, et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg. Jan 1999;103(1):1-9; discussion 10. [Medline].

  14. Radhakrishnan K, Rockson SG. Gorham's disease: an osseous disease of lymphangiogenesis?. Ann N Y Acad Sci. 2008;1131:203-5. [Medline].

  15. Price NJ, Cundy PJ. Synovial hemangioma of the knee. J Pediatr Orthop. Jan-Feb 1997;17(1):74-7. [Medline].

  16. Griffin N, Khan N, Thomas JM, Fisher C, Moskovic EC. The radiological manifestations of intramuscular haemangiomas in adults: magnetic resonance imaging, computed tomography and ultrasound appearances. Skeletal Radiol. Nov 2007;36(11):1051-9. [Medline].

  17. Vilanova JC, Barceló J, Smirniotopoulos JG, Pérez-Andrés R, Villalón M, Miró J, et al. Hemangioma from head to toe: MR imaging with pathologic correlation. Radiographics. Mar-Apr 2004;24(2):367-85. [Medline].

  18. Greenspan A, Azouz EM, Matthews J 2nd, Decarie JC. Synovial hemangioma: imaging features in eight histologically proven cases, review of the literature, and differential diagnosis. Skeletal Radiol. Nov 1995;24(8):583-90. [Medline].

  19. O'Connell JX, Kattapuram SV, Mankin HJ. Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol. Jun 1993;17(6):610-7. [Medline].

  20. Enzinger FM, Weiss SW. Soft Tissue Tumors. St. Louis:. Mosby-Year Book;1995:579-626.

  21. Cohen AJ, Youkey JR, Clagett GP, et al. Intramuscular hemangioma. JAMA. May 20 1983;249(19):2680-2. [Medline].

  22. Bremnes RM, Hauge HN, Sagsveen R. Radiotherapy in the treatment of symptomatic vertebral hemangiomas: technical case report. Neurosurgery. Nov 1996;39(5):1054-8. [Medline].

  23. Henley JD, Danielson CF, Rothenberger SS, et al. Kasabach-Merritt syndrome with profound platelet support. Am J Clin Pathol. May 1993;99(5):628-30. [Medline].

  24. de Prost Y, Teillac D, Bodemer C, et al. Successful treatment of Kasabach-Merritt syndrome with pentoxifylline. J Am Acad Dermatol. Nov 1991;25(5 Pt 1):854-5. [Medline].

  25. Beham A, Fletcher CD. Intramuscular angioma: a clinicopathological analysis of 74 cases. Histopathology. Jan 1991;18(1):53-9. [Medline].

  26. Buetow PC, Kransdorf MJ, Moser RP Jr, et al. Radiologic appearance of intramuscular hemangioma with emphasis on MR imaging. AJR Am J Roentgenol. Mar 1990;154(3):563-7. [Medline].

  27. Kenan S, Abdelwahab IF, Klein MJ, Lewis MM. Hemangiomas of the long tubular bone. Clin Orthop. Jul 1992;(280):256-60. [Medline].

  28. Maki DD, Craig-Mueller J, Griffiths HJ. Radiologic case study. Intramuscular hemangioma. Orthopedics. Oct 1996;19(10):916, 907-9. [Medline].

  29. Paley D, Evans DC. Angiomatous involvement of an extremity. A spectrum of syndromes. Clin Orthop. May 1986;(206):215-8. [Medline].

  30. Petasnick JP, Turner DA, Charters JR, et al. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology. Jul 1986;160(1):125-33. [Medline].

  31. Pritchard DJ. Surgical management of common benign soft-tissue tumors. In: Simon MA, Springfield D, eds. Surgery for Bone and Soft-tissue Tumors. Philadelphia:. Lippincott-Raven Publishers;1998:534-537.

  32. Rogalski R, Hensinger R, Loder R. Vascular abnormalities of the extremities: clinical findings and management. J Pediatr Orthop. Jan-Feb 1993;13(1):9-14. [Medline].

  33. Sherman RS, Wilner D. The roentgen diagnosis of hemangioma of bone. Am J Roentgenol Radium Ther Nucl Med. Dec 1961;86:1146-59. [Medline].

  34. Sung MS, Kang HS, Lee HG. Regional bone changes in deep soft tissue hemangiomas: radiographic and MR features. Skeletal Radiol. Apr 1998;27(4):205-10. [Medline].

  35. Unni KK. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. Philadelphia:. Lippincott-Raven Publishers;1996:307-316.

  36. Unni KK, Ivins JC, Beabout JW, Dahlin DC. Hemangioma, hemangiopericytoma, and hemangioendothelioma (angiosarcoma) of bone. Cancer. Jun 1971;27(6):1403-14. [Medline].

  37. Weinstein JN, Boriani S, Phillips FM, Wetzel FT. Management of benign tumors of the spine. In: Simon MA, Springfield D, eds. Surgery for Bone and Soft-tissue Tumors. Philadelphia:. Lippincott-Raven Publishers;1998:212-214.

  38. Wenger DE, Wold LE. Benign vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol. Feb 2000;29(2):63-74. [Medline].

  39. Wild AT, Raab P, Krauspe R. Hemangioma of skeletal muscle. Arch Orthop Trauma Surg. 2000;120(3-4):139-43. [Medline].

Further Reading

Keywords

hemangioma, benign vascular tumor, senile hemangioma, cherry hemangioma, strawberry nevus, visceral hemangioma, intramuscular hemangioma, hemangioma of the bone, hemangiomatosis, skeletal-extraskeletal angiomatosis, vertebral hemangioma, Kasabach-Merritt syndrome, tumor-induced osteomalacia, Gorham disease, disappearing bone disease, osteolysis, hemangiomatous disease, enchondromatosis, Maffucci syndrome, synovial hemangioma, osseous hemangioma

Contributor Information and Disclosures

Author

Danielle A Katz, MD, Assistant Professor, Department of Orthopedic Surgery, State University of New York Upstate Medical University
Danielle A Katz, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American College of Surgeons, and Pediatric Orthopaedic Society of North America
Disclosure: Nothing to disclose.

Coauthor(s)

Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Timothy A Damron, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, Children's Oncology Group, Connective Tissue Oncology Society, Musculoskeletal Tumor Society, Orthopaedic Research Society, and Society for Experimental Biology and Medicine
Disclosure: Lippincott, Williams, and Wilkins Royalty Editing/writing textbook; Genentech Grant/research funds Clinical research; Orthovita Grant/research funds Clinical research; National Institutes of Health Grant/research funds Clinical research

Medical Editor

Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Timothy A Damron, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, Children's Oncology Group, Connective Tissue Oncology Society, Musculoskeletal Tumor Society, Orthopaedic Research Society, and Society for Experimental Biology and Medicine
Disclosure: Lippincott, Williams, and Wilkins Royalty Editing/writing textbook; Genentech Grant/research funds Clinical research; Orthovita Grant/research funds Clinical research; National Institutes of Health Grant/research funds Clinical research

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Sean P Scully, MD, PhD, Professor, Department of Orthopedics, University of Miami
Sean P Scully, MD, PhD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, International Society on Thrombosis and Haemostasis, and Society of Surgical Oncology
Disclosure: Nothing to disclose.

CME Editor

Dinesh Patel, MD, FACS, Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital
Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Physicians of Indian Origin, American College of International Physicians, and American College of Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Harris Gellman, MD, Consulting Surgeon, Broward Hand Center; Voluntary Clinical Professor of Orthopedic Surgery and Plastic Surgery, Departments of Orthopedic Surgery and Surgery, University of Miami School of Medicine
Harris Gellman, MD is a member of the following medical societies: American Academy of Medical Acupuncture, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Society for Surgery of the Hand, and Arkansas Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.